Optimal working dilution should be determined by the investigator.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
1.0 mg/mL
OBrien, Romero-Gallo, Schneider, Chaturvedi, Delgado, Harris, Krishna, Ogden, Israel, Wilson, Peek: "Regulation of the Helicobacter pylori cellular receptor decay-accelerating factor." in: The Journal of biological chemistry, Vol. 283, Issue 35, pp. 23922-30, (2008) (PubMed).
van Holten, Pavelka, Vencovsky, Stahl, Rozman, Genovese, Kivitz, Alvaro, Nuki, Furst, Herrero-Beaumont, McInnes, Musikic, Tak: "A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis." in: Annals of the rheumatic diseases, Vol. 64, Issue 1, pp. 64-9, (2004) (PubMed).